Kara L Vine
TitleCited byYear
Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008
KL Vine, L Matesic, JM Locke, M Ranson, D Skropeta
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2009
2292009
In vitro cytotoxicity evaluation of some substituted isatin derivatives
KL Vine, JM Locke, M Ranson, SG Pyne, JB Bremner
Bioorganic & medicinal chemistry 15 (2), 931-938, 2007
2052007
An investigation into the cytotoxicity and mode of action of some novel N-alkyl-substituted isatins
KL Vine, JM Locke, M Ranson, SG Pyne, JB Bremner
Journal of medicinal chemistry 50 (21), 5109-5117, 2007
1442007
N-phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents
L Matesic, JM Locke, JB Bremner, SG Pyne, D Skropeta, M Ranson, ...
Bioorganic & medicinal chemistry 16 (6), 3118-3124, 2008
822008
Gastric cancer stem cells: evidence, potential markers, and clinical implications
D Brungs, M Aghmesheh, KL Vine, TM Becker, MG Carolan, M Ranson
Journal of gastroenterology 51 (4), 313-326, 2016
542016
Recent highlights in the development of isatin-based anticancer agents
KL Vine, L Matesic, JM Locke, D Skropeta
Adv. Anticancer Agents Med. Chem 2, 254-312, 2013
422013
SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation
R Zeineddine, JF Pundavela, L Corcoran, EM Stewart, D Do-Ha, M Bax, ...
Molecular neurodegeneration 10 (1), 57, 2015
382015
Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
L Belfiore, DN Saunders, M Ranson, KJ Thurecht, G Storm, KL Vine
Journal of controlled release 277, 1-13, 2018
342018
Biopolymers for antitumor implantable drug delivery systems: Recent advances and future outlook
S Talebian, J Foroughi, SJ Wade, KL Vine, A Dolatshahi‐Pirouz, ...
Advanced Materials 30 (31), 1706665, 2018
262018
SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer
NLE Harris, C Vennin, JRW Conway, KL Vine, M Pinese, MJ Cowley, ...
Oncogene 36 (30), 4288, 2017
262017
Synthesis and anti-leukaemic activity of pyrrolo [3, 2, 1-hi] indole-1, 2-diones, pyrrolo [3, 2, 1-ij] quinoline-1, 2-diones and other polycyclic isatin derivatives
L Matesic, JM Locke, KL Vine, M Ranson, JB Bremner, D Skropeta
Tetrahedron 68 (34), 6810-6819, 2012
262012
A proposed functional role for indole derivatives in reproduction and defense of the Muricidae (Neogastropoda: Mollusca)
CB Westley, KL Vine, K Benkendorff
Indirubin, the Red Shade of Indigo, 31-44, 2006
262006
Anti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptor
VI Chandran, L Matesic, JM Locke, D Skropeta, M Ranson, KL Vine
Cancer letters 316 (2), 151-156, 2012
212012
The CD-loop of PAI-2 (SERPINB2) is redundant in the targeting, inhibition and clearance of cell surface uPA activity
BJ Cochran, LP Gunawardhana, KL Vine, JA Lee, S Lobov, M Ranson
BMC biotechnology 9 (1), 43, 2009
212009
Improving the delivery of SOD1 antisense oligonucleotides to motor neurons using calcium phosphate-lipid nanoparticles
L Chen, C Watson, M Morsch, NJ Cole, RS Chung, DN Saunders, ...
Frontiers in neuroscience 11, 476, 2017
192017
HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer
VI Chandran, S Eppenberger-Castori, T Venkatesh, KL Vine, M Ranson
Oncoscience 2 (3), 207, 2015
192015
Synthesis and hydrolytic evaluation of acid-labile imine-linked cytotoxic isatin model systems
L Matesic, JM Locke, KL Vine, M Ranson, JB Bremner, D Skropeta
Bioorganic & medicinal chemistry 19 (5), 1771-1778, 2011
192011
Probing the pharmacokinetics of cucurbit [7, 8 and 10] uril: and a dinuclear ruthenium antimicrobial complex encapsulated in cucurbit [10] uril
F Li, AK Gorle, M Ranson, KL Vine, R Kinobe, M Feterl, JM Warner, ...
Organic & biomolecular chemistry 15 (19), 4172-4179, 2017
172017
Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles
TK Stutchbury, KL Vine, JM Locke, JS Chrisp, JB Bremner, PR Clingan, ...
Anti-cancer drugs 22 (1), 24-34, 2011
142011
Selective targeting of 2′-deoxy-5-fluorouridine to urokinase positive malignant cells in vitro
KL Vine, JM Locke, JB Bremner, SG Pyne, M Ranson
Bioorganic & medicinal chemistry letters 20 (9), 2908-2911, 2010
142010
The system can't perform the operation now. Try again later.
Articles 1–20